Invesaro

Stocks Health care NATR

NASDAQ · Health care

Natures Sunshine Products Inc (NATR)

Natures Sunshine Products Inc brought in $480.3M of revenue over the twelve months to September 30, 2026, up 1.2% from a year earlier. Net income was $14.7M, a net margin of 3.1%. Operating cash flow minus capital spending left $28.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $89.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.

Free, no password. An email when NATR files with the SEC.

Price
$10.93
-0.82% on the day · November 10, 2026
52-week range $9.38 to $28.14
Market cap
$192.3M
Revenue (last 12 months)
$480.3M
+1.2% year on year
Net margin
3.1%
P/E
10.3
on FY2025 diluted EPS

Key facts about Natures Sunshine Products Inc

Net worth
Natures Sunshine Products Inc has a market value (market cap) of $192.3M at the latest share price, and shareholders' equity of $171.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $480.1M (+5.7% year on year), with net income of $19.5M. Over the 12 months to September 30, 2026: revenue $480.3M, net income $14.7M.
Cash flow
In fiscal 2025 operations brought in $35.3M of cash; after $6.5M of capital spending, free cash flow was $28.8M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Natures Sunshine Products Inc's next report is expected around March 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Natures Sunshine Products Inc does

Natures Sunshine Products Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NATR.

Revenue and profit by year

Revenue
FY18: $364.8M $364.8M FY18FY19: $362.2M $362.2M FY19FY20: $385.2M $385.2M FY20FY21: $444.1M $444.1M FY21FY22: $421.9M $421.9M FY22FY23: $445.3M $445.3M FY23FY24: $454.4M $454.4M FY24FY25: $480.1M $480.1M FY25
Net income
FY18: -$854K -$854K FY18FY19: $6.8M $6.8M FY19FY20: $21.3M $21.3M FY20FY21: $28.9M $28.9M FY21FY22: -$390K -$390K FY22FY23: $15.1M $15.1M FY23FY24: $7.7M $7.7M FY24FY25: $19.5M $19.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$480.1M$24.7M$19.5M$1.06$28.8M
2024$454.4M$20.1M$7.7M$0.40$14.3M
2023$445.3M$18.7M$15.1M$0.77$30.7M
2022$421.9M$16.3M-$390K-$0.02-$6.9M
2021$444.1M$34.7M$28.9M$1.42$27.9M
2020$385.2M$21.5M$21.3M$1.07$32.8M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around March 9, 2027.

Estimated from its filing rhythm: 52 weeks after its report of March 10, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where NATR ranks in Health care

Revenue$480.1M
#208 of 751 in Health care · Top 28%
Revenue growth+5.7%
#344 of 532 in Health care · Bottom 35%
Net margin4.1%
#172 of 544 in Health care · Top 31%
Free cash flow margin6.0%
#164 of 490 in Health care · Top 33%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2022$0.00$0n/a
2021$1.00$19.9M69%
2020$0.00$00%
2019$0.00n/an/a
2018$0.00$0n/a
2017$0.10$1.8Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Natures Sunshine Products Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 4, 2026
  2. November 4, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue fell 9.1% to $116.6M versus the same quarter last year; diluted EPS $0.11 versus $0.30.
  3. October 27, 2026
  4. August 10, 2026
  5. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 1.9% to $117M versus the same quarter last year; diluted EPS $0.19 versus $0.28.
  6. August 6, 2026
  7. May 15, 2026
  8. May 11, 2026
  9. May 7, 2026
  10. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 8.5% to $122.9M versus the same quarter last year; diluted EPS $0.29 versus $0.25.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 9, 2026. Insider transactions on SEC

What is NATR worth? A DCF from its reported cash flow

Insider trades

What the people running Natures Sunshine Products Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $3.1M worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$3.1M
last 90 days
Sold
$0
last 90 days
Net bought
311,666
$3.1M
DateInsiderWhatSharesPriceValueFiling
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 781 $9.50 $7.4K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 128 $9.52 $1.2K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 59,872 $9.55 $571.8K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 10,000 $9.56 $95.6K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 9,485 $9.61 $91.2K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 7,980 $9.63 $76.8K Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 6 $9.66 $58 Form 4
November 5, 2026 Prescott Group Capital Management, L.L.C.10% owner Boughtindirect 30 $9.71 $291.3 Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NATR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Prescott Group Capital Management, L.L.C.13G, passive with 4 related filers 10.9% 1,924,486 August 10, 2026
Dimensional Fund Advisors LP13G, passive 5.2% 913,791 October 9, 2025

Latest filings below 5%: BlackRock, Inc. 4.97% (October 27, 2026); Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 0.35% (June 27, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 153 managers reported a position.

HolderSharesValueChange on quarter
Wynnefield Capital Inc2,473,686$53.9M0
Prescott Group Capital Management, L.L.C.1,783,097$38.9M0
BlackRock, Inc.989,020$21.6M-75,434
Dimensional Fund Advisors LP923,626$20.1M+28,189
American Century Companies Inc714,829$15.6M+140,004
Kennedy Capital Management LLC623,831$13.6M-67,667
Vanguard Capital Management LLC604,411$13.2M+7,578
Renaissance Technologies LLC527,568$11.5M-4,356
Geode Capital Management, LLC379,914$8.3M+7,365
Punch & Associates Investment Management, Inc.340,000$7.4M0
State Street Corp326,890$7.1M+1,085
Hillsdale Investment Management Inc.304,607$6.6M-12,260
Vanguard Portfolio Management LLC289,408$6.3M+172,555
Boston Partners262,663$5.7M+42,470
Morgan Stanley235,491$5.1M-32,466
Jacobs Levy Equity Management, Inc214,189$4.7M+22,502
Nuveen, LLC208,892$4.6M+36,795
Bfsg, LLC198,861$4.3M+99,212
First Eagle Investment Management, LLC197,600$4.3M+98,800
Arrowstreet Capital, Limited Partnership191,251$4.2M+19,401

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

18 insiders reported holding 3,105,196 shares in total, about $33.9M at the last price.

HolderSharesAs of
Prescott Group Capital Management, L.L.C.10% owner 2,236,1522,236,152 held indirectly November 5, 2026
Romanzi Kenneth G.Chief Executive Officer, Director 128,978 November 4, 2026
Jones Leslie ShaneEVP & Chief Financial Officer 104,658 May 5, 2026
Yates Bryant JEVP & President, Europe 79,114 November 4, 2026
Perkins Ruth AnnEVP, Chief Financial Officer 75,433 September 2, 2026
Straus Robert DDirector 56,514 May 15, 2026
Lanoy Jonathan DavidSVP, Chief Accounting Officer 56,360 November 4, 2026
Norman Daniel CEVP & President, Asia 48,944 November 4, 2026
Herbert Kevin R.EVP & President, North America 46,890 June 26, 2026
Brower Nathan GEVP, General Counsel 44,811 November 4, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NATR

What does Natures Sunshine Products Inc do?

Natures Sunshine Products Inc is a company in the Health care sector, listed on NASDAQ as NATR. Its shares trade on NASDAQ under the ticker NATR.

What is Natures Sunshine Products Inc's net worth?

Natures Sunshine Products Inc has a market value (market cap) of $192.3M at the latest share price, and shareholders' equity of $171.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Natures Sunshine Products Inc profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $14.7M on revenue of $480.3M, a net margin of 3.1%.

How much revenue does Natures Sunshine Products Inc make?

Over the twelve months to September 30, 2026 Natures Sunshine Products Inc reported revenue of $480.3M. That is 1.2% more than a year earlier.

When did Natures Sunshine Products Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade from November 9, 2026.

When is Natures Sunshine Products Inc's next earnings report?

Natures Sunshine Products Inc's next report is expected around March 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare NATR with

Compare NATR with any company

Follow NATR

Get an email when Natures Sunshine Products Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when NATR files with the SEC.

Where the numbers come from

Financial figures are the values Natures Sunshine Products Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.